Table of Contents
ISRN Chromatography
Volume 2012, Article ID 892806, 6 pages
http://dx.doi.org/10.5402/2012/892806
Research Article

Quantifying Solid-State Mixtures of Crystalline Indomethacin by Raman Spectroscopy Comparison with Thermal Analysis

1Department of Pharmaceutical Sciences, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, 179 Longwood Avenue, Boston, MA 02115, USA
2School of Pharmacy and Health Professions, Creighton University, Hixson-Lied Building. 152, 2500 California Plaza, Omaha, NE 68178, USA
3Department of Chemistry and Chemical Biology, Northeastern University, 414 Hurtig Hall, Boston, MA 02115, USA

Received 7 December 2011; Accepted 25 December 2011

Academic Editor: R. Nageswara Rao

Copyright © 2012 Eman Atef et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. G. Brittain, “Polymorphism and solvatomorphism 2005,” Journal of Pharmaceutical Sciences, vol. 96, no. 4, pp. 705–728, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. R. W. Lancaster, P. G. Karamertzanis, A. T. Hulme, D. A. Tocher, T. C. Lewis, and S. L. Price, “The polymorphism of progesterone: stabilization of a “disappearing” polymorph by co-crystallization,” Journal of Pharmaceutical Sciences, vol. 96, no. 12, pp. 3419–3431, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. J. Bauer, S. Spanton, R. Henry et al., “Ritonavir: an extraordinary example of conformational polymorphism,” Pharmaceutical Research, vol. 18, no. 6, pp. 859–866, 2001. View at Publisher · View at Google Scholar
  4. J. E. Patterson, M. B. James, A. H. Forster, R. W. Lancaster, J. M. Butler, and T. Rades, “The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds,” Journal of Pharmaceutical Sciences, vol. 94, no. 9, pp. 1998–2012, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. A. K. Tiwary, “Modification of crystal habit and its role in dosage form performance,” Drug Development and Industrial Pharmacy, vol. 27, no. 7, pp. 699–709, 2001. View at Publisher · View at Google Scholar
  6. N. Sandler, J. Rantanen, J. Heinämäki, M. Römer, M. Marvola, and J. Yliruusi, “Pellet manufacturing by extrusion-spheronization using process analytical technology,” AAPS PharmSciTech, vol. 6, no. 2, article 26, pp. E174–E183, 2005. View at Publisher · View at Google Scholar · View at PubMed
  7. S. Airaksinen, M. Karjalainen, E. Räsänen, J. Rantanen, and J. Yliruusi, “Comparison of the effects of two drying methods on polymorphism of theophylline,” International Journal of Pharmaceutics, vol. 276, no. 1-2, pp. 129–141, 2004. View at Publisher · View at Google Scholar · View at PubMed
  8. M. E. Auer, U. J. Griesser, and J. Sawatzki, “Qualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy,” Journal of Molecular Structure, vol. 661-662, no. 1–3, pp. 307–317, 2003. View at Publisher · View at Google Scholar
  9. K. Pöllänen, A. Häkkinen, S. Reinikainen et al., “IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product,” Journal of Pharmaceutical and Biomedical Analysis, vol. 38, no. 2, pp. 275–284, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. M. Trifkovic, S. Rohani, and M. Mirmehrabi, “Polymorphic generation through solvent selection: ranitidine hydrochloride,” Organic Process Research and Development, vol. 11, no. 1, pp. 138–143, 2007. View at Publisher · View at Google Scholar
  11. R. Lefort, A. De Gusseme, J. F. Willart, F. Danède, and M. Descamps, “Solid state NMR and DSC methods for quantifying the amorphous content in solid dosage forms: an application to ball-milling of trehalose,” International Journal of Pharmaceutics, vol. 280, no. 1-2, pp. 209–219, 2004. View at Publisher · View at Google Scholar · View at PubMed
  12. H. Ahmed, G. Buckton, and D. A. Rawlins, “The use of isothermal microcalorimetry in the study of small degrees of amorphous content of a hydrophobic powder,” International Journal of Pharmaceutics, vol. 130, no. 2, pp. 195–201, 1996. View at Publisher · View at Google Scholar
  13. Z. Német, G. C. Kis, G. Pokol, and A. Demeter, “Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 49, no. 2, pp. 338–346, 2009. View at Publisher · View at Google Scholar · View at PubMed
  14. E. M. Phillips, “An approach to estimate the amorphous content of pharmaceutical powders using calorimetry with no calibration standards,” International Journal of Pharmaceutics, vol. 149, no. 2, pp. 267–271, 1997. View at Publisher · View at Google Scholar
  15. B. Shah, V. K. Kakumanu, and A. K. Bansal, “Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids,” Journal of Pharmaceutical Sciences, vol. 95, no. 8, pp. 1641–1665, 2006. View at Publisher · View at Google Scholar · View at PubMed
  16. A. Heinz, M. Savolainen, T. Rades, and C. J. Strachan, “Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy,” European Journal of Pharmaceutical Sciences, vol. 32, no. 3, pp. 182–192, 2007. View at Publisher · View at Google Scholar · View at PubMed
  17. Y. Hu, H. Wikström, S. R. Byrn, and L. S. Taylor, “Analysis of the effect of particle size on polymorphic quantitation by Raman spectroscopy,” Applied Spectroscopy, vol. 60, no. 9, pp. 977–984, 2006. View at Publisher · View at Google Scholar · View at PubMed
  18. A. L. Enculescu and J. R. Steiginga, “Raman spectroscopy—a powerful tool for non-routine analysis of pharmaceuticals,” American Pharmaceutical Review, vol. 5, no. 1, pp. 81–88, 2002. View at Google Scholar
  19. A. W. Newman and S. R. Byrn, “Solid-state analysis of the active pharmaceutical ingredient in drug products,” Drug Discovery Today, vol. 8, no. 19, pp. 898–905, 2003. View at Publisher · View at Google Scholar
  20. N. Kaneniwa, M. Otsuka, and T. Hayashi, “Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol,” Chemical and Pharmaceutical Bulletin, vol. 33, no. 8, pp. 3447–3455, 1985. View at Google Scholar
  21. L. S. Taylor and G. Zografi, “Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions,” Pharmaceutical Research, vol. 14, no. 12, pp. 1691–1698, 1997. View at Publisher · View at Google Scholar
  22. X. Pan, T. Julian, and L. Augsburger, “Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethicin,” Drug Development and Industrial Pharmacy, vol. 34, no. 2, pp. 221–231, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. J. Johansson, S. Pettersson, and S. Folestad, “Characterization of different laser irradiation methods for quantitative Raman tablet assessment,” Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 3-4, pp. 510–516, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. M. E. Auer, U. J. Griesser, and J. Sawatzki, “Qualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy,” Journal of Molecular Structure, vol. 661-662, no. 1–3, pp. 307–317, 2003. View at Publisher · View at Google Scholar
  25. S. Virtanen, O. Antikainen, and J. Yliruusi, “Determination of the crushing strength of intact tablets using Raman spectroscopy,” International Journal of Pharmaceutics, vol. 360, no. 1-2, pp. 40–46, 2008. View at Publisher · View at Google Scholar · View at PubMed
  26. E. Atef, H. Chauhan, M. Ceresia, and C. Pidgeon, “Using Raman spectroscopy in tablet moisture surface analysis: tablet surface markers,” Journal of Pharmaceutical and Biomedical Analysis, vol. 53, no. 4, pp. 852–859, 2010. View at Publisher · View at Google Scholar · View at PubMed
  27. C. McGregor and E. Bines, “The use of high-speed differential scanning calorimetry (Hyper-DSC) in the study of pharmaceutical polymorphs,” International Journal of Pharmaceutics, vol. 350, no. 1-2, pp. 48–52, 2008. View at Publisher · View at Google Scholar · View at PubMed
  28. C. McGregor, M. H. Saunders, G. Buckton, and R. D. Saklatvala, “The use of high-speed differential scanning calorimetry (Hyper-DSC) to study the thermal properties of carbamazepine polymorphs,” Thermochimica Acta, vol. 417, no. 2, pp. 231–237, 2004. View at Publisher · View at Google Scholar